In a 12-month period that has seen drug compounders linked to horse deaths at a training center and integrity issues at the track, the Kentucky Horse Racing Commission is researching ways it could add regulatory oversight.
The U.S. Food and Drug Administration reports the number of Thoroughbreds who died after receiving a compounded drug from Wickliffe Pharmacy in Lexington, Ky. has grown to four, and six others have become ill.
The RMTC will recommend the anabolic steroid stanozolol, currently permitted for therapeutic use up to 30 days prior to racing, be eliminated from the list of substances with a recommended threshold level.
Scientists are warning horse owners and veterinarians to be cautious about using compounded (private pharmacy-mixed) gastric ulcer medications.
Most Popular Stories
- Nyquist Draws Post 13, is 3-1 Derby Favorite
- Field of 22 Set for 142nd Kentucky Derby
- Bensons Hope to Let Good Times Roll in Derby
- Court Ruling Important in Hobby Law Tax Cases
- Fresh Horses Plentiful in 2016 Kentucky Derby
- Trainer Abrams Takes Leave of Absence
- Rachel's Valentina 7-2 Oaks Favorite
- Ramseys Go It Alone with Oscar Nominated
- Full Gate for Pat Day Mile
- Former Derby Hopefuls Meet in American Turf